Prospective Observational Cohort Study of Moderate Aortic Valve Disease
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorSecond Affiliated Hospital, School of Medicine, Zhejiang University
About this trial
The objective of this research is to evaluate and predict the progression of moderate aortic stenosis and regurgitation from clinical characterization, biological, echocardiographic, and computed tomography (CT) et. al. Additionally, try to analyze the potential impact of device or drug therapy on the progression of the conditions.
Eligibility criteria
Qualifiers
At least 18 years old
Be willing and able to provide informed consent to participate in the study
Patient has moderate aortic valve diseases with echocardiographically derived criteria
Disqualifiers
Severe aortic valve diseases with echocardiographically derived criteria or planned cardiac surgery or likely need for surgery within 6 months
Patients who have undergone elective transfemoral transcatheter aortic valve replacement
Life expectancy is less than 12 months due to non-heart disease (such as cancer, chronic liver disease, chronic kidney disease, or chronic end-stage lung disease, etc.)
Severe dementia (cannot sign research informed consent, cannot take care of themselves or complete the study visit)
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Sponsors and collaborators
Source ClinicalTrials.gov